E-LIB Suche - Ergebnisse für: Giglio, Norberto

1

The economic rationale for cell-based influenza vaccines in..:

Fisman, David ; Giglio, Norberto ; Levin, Myron J....
Human Vaccines & Immunotherapeutics. 20 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

2

Efficacy of an extensively hydrolyzed formula with the addi..:

Soria, Ramiro ; Del Compare, Mónica ; Sallaberry, Marisa...
Frontiers in Allergy. 4 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

3

Real-World Evidence in Cost-Effectiveness Analysis of Enhan..:

Postma, Maarten ; Fisman, David ; Giglio, Norberto...
Vaccines. 11 (2023) 6 - p. 1089 , 2023

Link: https://doi.org/10.3390/..

4

Meningococcal burden of disease in Argentina: 10 years epid..:

Neyro, Silvina ; Urueña, Analia ; Efron, Adriana...
Human Vaccines & Immunotherapeutics. 19 (2023) 2 - p. , 2023

Link: https://doi.org/10.1080/..

5

Estimating the health economic impact of the universal vari..:

Giglio, Norberto ; Lasalvia, Pieralessandro ; Pawaskar, Manjiri...
Human Vaccines & Immunotherapeutics. 19 (2023) 2 - p. , 2023

Link: https://doi.org/10.1080/..

6

Background rates of adverse events of special interest for ..:

Phillips, Anastasia ; Jiang, Yannan ; Walsh, Donna...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.vaccine.2023.08.079. , 2023

Link: https://hal.science/hal-..

7

Meningococcal burden of disease in Argentina: 10 years epid..:

Silvina Neyro ; Analia Urueña ; Adriana Efron...
http://dx.doi.org/10.1080/21645515.2023.2237391. , 2023

Link: https://doi.org/10.1080/..

8

Background rates of adverse events of special interest for ..:

Phillips, Anastasia ; Jiang, Yannan ; Walsh, Donna...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.vaccine.2023.08.079. , 2023

Link: https://hal.science/hal-..

9

Efficacy of an extensively hydrolyzed formula with the addi..:

Soria, Ramiro ; Del Compare, Mónica ; Sallaberry, Marisa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591099/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Real-World Evidence in Cost-Effectiveness Analysis of Enhan..:

Maarten Postma ; David Fisman ; Norberto Giglio...
https://dx.doi.org/10.3390/vaccines11061089. , 2023

Link: https://doi.org/10.3390/..

11

Real-World Evidence in Cost-Effectiveness Analysis of Enhan..:

Maarten Postma ; David Fisman ; Norberto Giglio...
https://www.mdpi.com/2076-393X/11/6/1089. , 2023

Link: https://doi.org/10.3390/..

12

Table1_Efficacy of an extensively hydrolyzed formula with t..:

Ramiro Soria ; Mónica Del Compare ; Marisa Sallaberry...
doi:10.3389/falgy.2023.1265083.s001. , 2023

Link: https://doi.org/10.3389/..

13

Estimating the health economic impact of the universal vari..:

Norberto Giglio ; Pieralessandro Lasalvia ; Manjiri Pawaskar...
http://dx.doi.org/10.1080/21645515.2023.2245703. , 2023

Link: https://doi.org/10.1080/..

14

Real-World Evidence in Cost-Effectiveness Analysis of Enhan..:

Postma, Maarten ; Fisman, David ; Giglio, Norberto...
https://research.rug.nl/en/publications/96a7de32-eff8-4cff-9f96-8983c512f7f3. , 2023

Link: https://hdl.handle.net/1..

15

Efficacy of an extensively hydrolyzed formula with the addi..:

Ramiro Soria ; Mónica Del Compare ; Marisa Sallaberry...
https://www.frontiersin.org/articles/10.3389/falgy.2023.1265083/full. , 2023

Link: https://doi.org/10.3389/..